Office-Wide Innovative Solutions Opening for Scalable Solutions Office (SSO)
ID: ARPA-H-SOL-24-105Type: Solicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNIH ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H)Bethesda, MD, 208920004, USA

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715)

PSC

HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT (AN13)
Timeline
  1. 1
    Posted Mar 14, 2024, 9:19 PM UTC
  2. 2
    Updated Sep 25, 2024, 12:00 AM UTC
  3. 3
    Due Mar 4, 2029, 4:59 AM UTC
Description

The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting innovative solutions aimed at enhancing healthcare accessibility, affordability, and scalability. This opportunity invites universities, non-profits, small businesses, and similar entities to submit solution summaries and proposals that address health disparities, improve the distribution of healthcare technologies, and advance biomanufacturing innovations. The solicitation emphasizes the development of scalable technologies and collaborative distribution networks, with a focus on interdisciplinary approaches to revolutionize biomedicine and public health outcomes. Interested parties must submit their solution summaries by March 3, 2029, and can find further details and submission guidelines at https://solutions.arpa-h.gov. For inquiries, questions should be directed to the same website.

Point(s) of Contact
Files
Title
Posted
Sep 25, 2024, 11:34 PM UTC
The document outlines the guidelines for submissions in response to the ARPA-H-SOL-24-105 RFP Amendment 01. It serves as a template for interested parties to present innovative solutions addressing Health Security Framework (HSF) interest areas. Requirements include a cover letter detailing organization type, point of contact information, and a financial basis estimate. The core segments include a concept summary, focusing on innovative approaches to solve relevant problems, and an impact statement that outlines expected outcomes and disruptive potential compared to existing technologies. The document emphasizes the importance of detailing the final project deliverables, milestones, and key approaches, including potential risks and challenges. Team organization is highlighted, requiring a description of members' roles and expertise. Lastly, a comprehensive budget breakdown is required to ensure clarity in project costing. This document emphasizes structured, technical, and financial organization for successful grant proposals, ensuring that submissions align with federal guidelines and project objectives.
Sep 25, 2024, 11:34 PM UTC
Sep 25, 2024, 11:34 PM UTC
The Advanced Research Projects Agency for Health (ARPA-H) is issuing a solicitation (ARPA-H-SOL-24-105) for innovative healthcare solutions to enhance accessibility, affordability, and scalability in health care delivery. The solicitation invites universities, non-profits, small businesses, and similar entities to submit solution summaries and proposals focused on addressing health disparities, improving the distribution of healthcare technologies, and advancing biomanufacturing innovations. Key areas of interest include scalable technologies adaptable to diverse contexts, collaborative distribution networks for efficient healthcare delivery, and advancements in biomanufacturing to reduce costs and enhance domestic competitiveness. Proposals should emphasize novel solutions that leverage interdisciplinary approaches while adhering to ARPA-H’s standards for intellectual property and compliance with relevant federal regulations. The solicitation is open until March 3, 2029, with multiple awards anticipated, and all submissions must undergo a mandatory solution summary review before full proposal submission. ARPA-H aims to stimulate high-impact health research that cannot be easily addressed through traditional means, highlighting its commitment to revolutionizing biomedicine and public health outcomes.
Sep 25, 2024, 10:37 PM UTC
The ARPA-H-SOL-24-104 Amendment 01 outlines a structured template for submissions related to innovative solutions fostering significant advancements in health science frameworks (HSF). Applicants must detail their proposals, including organization type, project description, innovation impact, technological approach, team organization, and a basis of estimate. Key sections focus on summarizing the project concept, identifying innovative outcomes, and outlining the technological novelty compared to current options. Milestones, deliverables, and potential challenges such as technical risks and mitigation strategies must also be included. Furthermore, the breakdown of project costs—covering labor, materials, travel, and profit—should be transparently detailed to facilitate evaluation. This document serves as a comprehensive guide for entities seeking federal grants or responding to RFPs, ensuring that proposals are both structured and aligned with overarching governmental health science objectives.
Mar 28, 2024, 7:16 AM UTC
May 2, 2024, 9:40 PM UTC
May 2, 2024, 9:40 PM UTC
The solicitation from the Advanced Research Projects Agency for Health (ARPA-H), titled "ARPA-H Scalable Solutions Office Innovative Solutions Opening," invites proposals aimed at enhancing healthcare access and affordability through innovative technologies and collaborative approaches. Eligible applicants include universities, non-profits, and businesses, with a focus on rapid deployment of scalable health solutions, particularly targeting underserved communities and specific health challenges. Proposals must undergo a review process, beginning with a solution summary submission, and will be evaluated based on their scientific merit, potential impact, and proposer capabilities, with multiple awards anticipated based on proposal quality and available funding.
Mar 28, 2024, 7:16 AM UTC
The ARPA-H Innovative Solutions Opening (ISO) solicitation seeks proposals for innovative projects aimed at improving the scalability and affordability of healthcare solutions while addressing disparities in access and quality of care. Eligible applicants include universities, non-profits, and businesses, and submissions require a preliminary solution summary before the full proposal, with submissions open until March 3, 2025. The solicitation emphasizes interdisciplinary approaches and novel methodologies to advance biomedicine and has specific exclusions for incremental advancements or proposals strictly related to policy or infrastructure development.
Lifecycle
Title
Type
Solicitation
Similar Opportunities
Office-Wide Innovative Solutions Opening for Health Science Futures (HSF)
Buyer not available
The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the Innovative Solutions Opening (ISO) aimed at advancing healthcare technologies. This initiative seeks innovative, disease-agnostic research projects that can significantly improve health outcomes, focusing on areas such as maternal and fetal health, genetic therapies, and novel diagnostic tools. The solicitation emphasizes the development of transformative solutions rather than incremental research, with submissions required to follow a two-step process: an initial solution summary followed by a full proposal based on feedback received. Interested parties must submit their solution summaries by March 3, 2029, via the designated ARPA-H portal, and are encouraged to review the detailed submission guidelines outlined in the provided documentation.
Office-Wide Innovative Solutions Opening for Proactive Health Office (PHO)
Buyer not available
The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting innovative research proposals aimed at enhancing health outcomes via the Proactive Health Office (PHO). The initiative focuses on developing solutions that prioritize disease prevention, early intervention, and scalable wellness-promoting behaviors, moving away from traditional reactive healthcare models. This opportunity is significant for entities capable of delivering transformative health solutions, with proposals evaluated based on scientific merit and relevance, and funding potentially awarded through Other Transactions or Cooperative Agreements. Interested parties must submit a mandatory solution summary by March 3, 2029, and can direct inquiries to the designated contact via the provided submission platforms.
Office-Wide Innovative Solutions Opening for Resilient Systems Office (RSO)
Buyer not available
The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting innovative solutions aimed at enhancing the resilience of healthcare systems via its Resilient Systems Office (RSO). This opportunity invites submissions from eligible entities, including universities, nonprofits, and small businesses, to address systemic challenges in healthcare and public health by leveraging cutting-edge technologies that improve care quality and availability. The solicitation emphasizes the importance of sociotechnical system innovations and adaptive solutions that enhance the reliability and interoperability of health ecosystems. Interested parties must submit solution summaries for feedback before full proposal submissions, with the solicitation open until March 3, 2029. For further inquiries, submissions should be directed to the designated online platforms, and the primary contact email is provided in the solicitation details.
PROactive Solutions for Prolonging Resilience (PROSPR)
Buyer not available
The Department of Health and Human Services, through the Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the PROactive Solutions for Prolonging Resilience (PROSPR) program, aimed at developing interventions to extend the healthspan of Americans by addressing age-related health decline. This initiative seeks to negotiate multiple Other Transaction Agreements (OTs) with eligible entities, focusing on three key technical areas: the development of an intrinsic capacity score, repurposing FDA-approved interventions, and creating second-generation interventions. The program is significant for transforming geriatric medicine into a preventive care model, emphasizing health equity and proactive health management for aging populations. Interested proposers can find further details and submit inquiries to the PROSPR Team at PROSPR@arpa-h.gov, with key deadlines for proposal submissions set for April and May 2025.
Final Innovative Solutions Opening (ISO) ARPA-H Rare Disease AI/ML for Precision Integrated Diagnostics (RAPID)
Buyer not available
The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the Final Innovative Solutions Opening (ISO) under the Rare Disease AI/ML for Precision Integrated Diagnostics (RAPID) program. This initiative aims to significantly enhance the speed and accuracy of diagnosing rare diseases, which affect approximately 30 million Americans, by developing innovative diagnostic support tools and a sustainable data platform optimized for AI-driven solutions. The RAPID program encompasses two phases over 4.5 years, focusing on extensive data curation, multimodal patient data collections, and the establishment of an AI-driven data commons, with the goal of reducing diagnostic delays and improving health management for underserved populations. Proposals are due by April 24, 2025, and interested parties can direct inquiries to the RAPID Email Box at RAPID@ARPA-H.gov.
ADAPT Contract Research Organization Support Services
Buyer not available
The Department of Health and Human Services, through the Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for Contract Research Organization (CRO) support services under the ADAPT Contract Research Organization Support Services initiative. This program aims to enhance cancer treatment strategies by developing an adaptive cancer treatment platform that integrates advanced analysis techniques and biomarker discovery to improve patient outcomes for metastatic cancers. The selected contractor will manage clinical trial data, conduct biological assays, and ensure compliance with regulatory standards, with a contract period of one year and four optional renewal years. Proposals are due by April 18, 2025, at 1:00 PM ET, and interested parties should direct inquiries to Steven Snyder at steven.snyder@arpa-h.gov or Clare Sanchez at clare.sanchez@arpa-h.gov.
ARPA-H ImagiNg Data EXchange (INDEX)
Buyer not available
The Department of Health and Human Services, through the Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the Imaging Data Exchange (INDEX) program aimed at enhancing access to medical imaging data. This initiative seeks to develop a sustainable platform that connects medical imaging data providers with researchers and developers, addressing the growing demand for imaging services amidst a shortage of qualified radiologists by leveraging artificial intelligence and machine learning. The program is structured in two phases: Phase 0 focuses on business model development, while Phase 1 involves system design and participant enrollment, with an emphasis on ensuring diverse and representative datasets. Interested parties must submit their proposals by April 18, 2025, and can direct inquiries to the INDEX Team at INDEX@arpa-h.gov.
BARDA DRIVe EZ-BAA (EZBAA - 22-100-SOL-00003)
Buyer not available
The Department of Health and Human Services, through the Biomedical Advanced Research and Development Authority (BARDA), is soliciting innovative research proposals under the Easy Broad Agency Announcement (EZ-BAA) BAA-22-100-SOL-00003. The initiative aims to address high-risk biomedical challenges related to emerging infectious diseases and public health emergencies, with specific Areas of Interest (AOIs) including vaccine efficacy enhancement, portable viral diagnostics, and medical countermeasures for acute radiation syndrome. This opportunity is crucial for advancing public health preparedness and fostering innovation in medical technologies. Interested parties must have active registration with SAM.gov and are encouraged to submit abstracts by various deadlines, with the next significant closing date for AOI submissions set for March 15, 2024. For further inquiries, contact Sieaun Marks at DRIVeAcquisitions@hhs.gov.
Ocular Laboratory for Analysis of Biomarkers (OCULAB)
Buyer not available
The Department of Health and Human Services, through the Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the Ocular Laboratory for Analysis of Biomarkers (OCULAB) program, aimed at advancing the diagnosis and treatment of ocular conditions, particularly dry eye disease (DED). The initiative seeks innovative solutions to develop a continuous monitoring biosensor integrated with therapeutic delivery systems, leveraging AI for non-invasive treatment methods. This program is significant for enhancing patient care and healthcare equity through advanced biomarker analysis and technology. Interested parties can contact the OCULAB Team at OCULAB@ARPA-H.gov for further information, with multiple awards anticipated as part of this funding opportunity, which is open until March 31, 2025.
Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA)
Buyer not available
The Department of Health and Human Services, through the Biomedical Advanced Research and Development Authority (BARDA), is soliciting proposals under the Broad Agency Announcement (BAA) BAA-23-100-SOL-00004 for advanced research and development of Medical Countermeasures (MCMs) aimed at addressing public health threats such as chemical, biological, radiological, and nuclear (CBRN) incidents, as well as emerging infectious diseases and pandemic influenza. The initiative seeks to foster public-private partnerships to enhance the development and responsiveness of life-saving MCMs, emphasizing the importance of technological maturity, regulatory compliance, and manufacturing standards in the evaluation process. This opportunity is critical for strengthening national health security and improving preparedness for future public health emergencies, with an open submission period running until September 25, 2028, at 4:30 PM Eastern Time. Interested parties can direct inquiries to BARDA-BAA@hhs.gov for further information.